Trial Profile
Efficacy and safety of Exforge and Aimix in hypertensives
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Mar 2015
Price :
$35
*
At a glance
- Drugs Amlodipine/irbesartan (Primary) ; Amlodipine/valsartan (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 18 Mar 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 28 Feb 2015 Status changed from recruiting to active, no longer recruiting according to University Hospital Medical Information Network - Japan record.
- 20 Sep 2014 Planned number of patients changed from 80 to 60 as reported by University Hospital Medical Information Network - Japan